EPO Antikörper
Kurzübersicht für EPO Antikörper (ABIN6252344)
Target
Alle EPO Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Protein G affinity chromatography
-
Immunogen
- A human partial recombinant protein was used as the immunogen for the Erythropoietin antibody.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF: 1-2 μg/mL
Immunohistochemistry (FFPE): 4-8 μg/mL for 30 min at RT
Flow Cytometry: 0.5-1 μg/million cells in 0.1ml
Titering of the Erythropoietin antibody may be required for optimal performance. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- PBS with 0.1 mg/mL BSA and 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and Store at -20C. Avoid freez-thaw cycles.
-
-
- EPO (Erythropoietin (EPO))
-
Andere Bezeichnung
- Erythropoietin
-
Substanzklasse
- Hormone
-
Hintergrund
- Erythropoietin / EPO is a secreted, glycosylated cytokine hormone composed of four alpha helical bundles. It is the primary factor responsible for regulating erythropoiesis during steady-state conditions and in response to blood loss and hemorrhage in the adult organism. Erythropoietin is synthesized by the kidney and stimulates the proliferation and maturation of bone marrow erythroid precursor cells. The protein is found in the plasma and regulates red cell production by promoting erythroid differentiation and initiating hemoglobin synthesis.
-
Gen-ID
- 2056
-
UniProt
- P01588
-
Pathways
- JAK-STAT Signalweg, Hormone Activity, Negative Regulation of intrinsic apoptotic Signaling, Negative Regulation of Transporter Activity
Target
-